Impact of antimicrobial stewardship implementation on the antibiotic use and susceptibility in a Japanese long-term care hospital
Antimicrobial use (AMU) is closely related to the emergence of antimicrobial-resistant (AMR) bacteria. Meanwhile, long-term care hospitals (LTCHs) have been pointed out to be important reservoirs for AMR. However, evidence illustrating the association between AMU and AMR in LTCHs is lacking compared...
Saved in:
Published in | Journal of Infection and Chemotherapy Vol. 30; no. 2; pp. 134 - 140 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Netherlands
Elsevier Ltd
01.02.2024
Elsevier BV |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Antimicrobial use (AMU) is closely related to the emergence of antimicrobial-resistant (AMR) bacteria. Meanwhile, long-term care hospitals (LTCHs) have been pointed out to be important reservoirs for AMR. However, evidence illustrating the association between AMU and AMR in LTCHs is lacking compared to that of acute care hospitals.
We evaluated the impact of an antimicrobial stewardship (AS) program implementation, in a LTCH on AMU and antibiotic susceptibility between three periods: the pre-AS-period (pre-AS); the first period after AS implementation (post-AS 1), in which initiated recommendation the blood culture collection and definitive therapy by AS team; and the second period (post-AS 2), implementation of a balanced use of antibiotics was added.
After the AS implementation, a significant increase in the number of blood cultures collected was observed. Conversely, the AMU of piperacillin-tazobactam (PIPC/TAZ), which has activity against Pseudomonas aeruginosa, was increased and occupied 43.0% of all injectable AMU in post-AS 1 compared with that in pre-AS (35.5%). In the post-AS 2 period, we analyzed the %AUD and recommended hospital-wide PIPC/TAZ sparing; this resulted in the significant reduction in %AUD of PIPC/TAZ, which was associated with improved susceptibility of P. aeruginosa to PIPC/TAZ.
These results suggest that AS programs aimed at implementing antibiotic sparing may lead to improve AMR, highlighting the necessity of correcting overuse of a single class of antibiotics and usefulness of AMU monitoring in the LTCH setting. |
---|---|
AbstractList | Antimicrobial use (AMU) is closely related to the emergence of antimicrobial-resistant (AMR) bacteria. Meanwhile, long-term care hospitals (LTCHs) have been pointed out to be important reservoirs for AMR. However, evidence illustrating the association between AMU and AMR in LTCHs is lacking compared to that of acute care hospitals.
We evaluated the impact of an antimicrobial stewardship (AS) program implementation, in a LTCH on AMU and antibiotic susceptibility between three periods: the pre-AS-period (pre-AS); the first period after AS implementation (post-AS 1), in which initiated recommendation the blood culture collection and definitive therapy by AS team; and the second period (post-AS 2), implementation of a balanced use of antibiotics was added.
After the AS implementation, a significant increase in the number of blood cultures collected was observed. Conversely, the AMU of piperacillin-tazobactam (PIPC/TAZ), which has activity against Pseudomonas aeruginosa, was increased and occupied 43.0% of all injectable AMU in post-AS 1 compared with that in pre-AS (35.5%). In the post-AS 2 period, we analyzed the %AUD and recommended hospital-wide PIPC/TAZ sparing; this resulted in the significant reduction in %AUD of PIPC/TAZ, which was associated with improved susceptibility of P. aeruginosa to PIPC/TAZ.
These results suggest that AS programs aimed at implementing antibiotic sparing may lead to improve AMR, highlighting the necessity of correcting overuse of a single class of antibiotics and usefulness of AMU monitoring in the LTCH setting. Antimicrobial use (AMU) is closely related to the emergence of antimicrobial-resistant (AMR) bacteria. Meanwhile, long-term care hospitals (LTCHs) have been pointed out to be important reservoirs for AMR. However, evidence illustrating the association between AMU and AMR in LTCHs is lacking compared to that of acute care hospitals.BACKGROUNDAntimicrobial use (AMU) is closely related to the emergence of antimicrobial-resistant (AMR) bacteria. Meanwhile, long-term care hospitals (LTCHs) have been pointed out to be important reservoirs for AMR. However, evidence illustrating the association between AMU and AMR in LTCHs is lacking compared to that of acute care hospitals.We evaluated the impact of an antimicrobial stewardship (AS) program implementation, in a LTCH on AMU and antibiotic susceptibility between three periods: the pre-AS-period (pre-AS); the first period after AS implementation (post-AS 1), in which initiated recommendation the blood culture collection and definitive therapy by AS team; and the second period (post-AS 2), implementation of a balanced use of antibiotics was added.METHODSWe evaluated the impact of an antimicrobial stewardship (AS) program implementation, in a LTCH on AMU and antibiotic susceptibility between three periods: the pre-AS-period (pre-AS); the first period after AS implementation (post-AS 1), in which initiated recommendation the blood culture collection and definitive therapy by AS team; and the second period (post-AS 2), implementation of a balanced use of antibiotics was added.After the AS implementation, a significant increase in the number of blood cultures collected was observed. Conversely, the AMU of piperacillin-tazobactam (PIPC/TAZ), which has activity against Pseudomonas aeruginosa, was increased and occupied 43.0% of all injectable AMU in post-AS 1 compared with that in pre-AS (35.5%). In the post-AS 2 period, we analyzed the %AUD and recommended hospital-wide PIPC/TAZ sparing; this resulted in the significant reduction in %AUD of PIPC/TAZ, which was associated with improved susceptibility of P. aeruginosa to PIPC/TAZ.RESULTSAfter the AS implementation, a significant increase in the number of blood cultures collected was observed. Conversely, the AMU of piperacillin-tazobactam (PIPC/TAZ), which has activity against Pseudomonas aeruginosa, was increased and occupied 43.0% of all injectable AMU in post-AS 1 compared with that in pre-AS (35.5%). In the post-AS 2 period, we analyzed the %AUD and recommended hospital-wide PIPC/TAZ sparing; this resulted in the significant reduction in %AUD of PIPC/TAZ, which was associated with improved susceptibility of P. aeruginosa to PIPC/TAZ.These results suggest that AS programs aimed at implementing antibiotic sparing may lead to improve AMR, highlighting the necessity of correcting overuse of a single class of antibiotics and usefulness of AMU monitoring in the LTCH setting.CONCLUSIONSThese results suggest that AS programs aimed at implementing antibiotic sparing may lead to improve AMR, highlighting the necessity of correcting overuse of a single class of antibiotics and usefulness of AMU monitoring in the LTCH setting. |
Author | Mizutani, Ryunosuke Yamada, Hidetoshi Isobe, Takeshi Matsumoto, Minami Edagawa, Shunji Niino, Hideki Uesugi, Koichi Kurabayashi, Makoto Yamada, Takehiro Tomita, Masashi |
Author_xml | – sequence: 1 givenname: Makoto surname: Kurabayashi fullname: Kurabayashi, Makoto email: kurabayashi-ma@keijinkai.or.jp organization: Department of Pharmacy, Sapporo Nishimaruyama Hospital, 4-7-25, Maruyamanishimachi, Chuo-ku, Sapporo, 064-8557, Japan – sequence: 2 givenname: Takehiro surname: Yamada fullname: Yamada, Takehiro email: yamada-t@hus.ac.jp organization: Department of Pharmacotherapy, Faculty of Pharmaceutical Sciences, Hokkaido University of Science, 15-4-1, Maeda 7-jo, Teine-ku, Sapporo, 006-8585, Japan – sequence: 3 givenname: Masashi surname: Tomita fullname: Tomita, Masashi email: tomita-m@keijinkai.or.jp organization: Department of Pharmacy, Sapporo Nishimaruyama Hospital, 4-7-25, Maruyamanishimachi, Chuo-ku, Sapporo, 064-8557, Japan – sequence: 4 givenname: Minami surname: Matsumoto fullname: Matsumoto, Minami email: nishimaruyama-di@keijinkai.or.jp organization: Department of Pharmacy, Sapporo Nishimaruyama Hospital, 4-7-25, Maruyamanishimachi, Chuo-ku, Sapporo, 064-8557, Japan – sequence: 5 givenname: Ryunosuke surname: Mizutani fullname: Mizutani, Ryunosuke email: 117a157@stu.hus.ac.jp organization: Department of Pharmacotherapy, Faculty of Pharmaceutical Sciences, Hokkaido University of Science, 15-4-1, Maeda 7-jo, Teine-ku, Sapporo, 006-8585, Japan – sequence: 6 givenname: Koichi surname: Uesugi fullname: Uesugi, Koichi email: u-06koichi@asahikawa-med.ac.jp organization: Department of Pharmacotherapy, Faculty of Pharmaceutical Sciences, Hokkaido University of Science, 15-4-1, Maeda 7-jo, Teine-ku, Sapporo, 006-8585, Japan – sequence: 7 givenname: Hideki surname: Niino fullname: Niino, Hideki email: niino-hi@keijinkai.or.jp organization: Department of Infection Control and Prevention, Sapporo Nishimaruyama Hospital, 4-7-25, Maruyamanishimachi, Chuo-ku, Sapporo, 064-8557, Japan – sequence: 8 givenname: Hidetoshi surname: Yamada fullname: Yamada, Hidetoshi email: h-yamada.0725_pharm@keijinkai.or.jp organization: Department of Pharmacy, Sapporo Nishimaruyama Hospital, 4-7-25, Maruyamanishimachi, Chuo-ku, Sapporo, 064-8557, Japan – sequence: 9 givenname: Takeshi surname: Isobe fullname: Isobe, Takeshi email: isobe-ta@keijinkai.or.jp organization: Department of Infection Control and Prevention, Sapporo Nishimaruyama Hospital, 4-7-25, Maruyamanishimachi, Chuo-ku, Sapporo, 064-8557, Japan – sequence: 10 givenname: Shunji orcidid: 0000-0001-7336-0734 surname: Edagawa fullname: Edagawa, Shunji email: edagawa-sh@keijinkai.or.jp organization: Department of Infection Control and Prevention, Sapporo Nishimaruyama Hospital, 4-7-25, Maruyamanishimachi, Chuo-ku, Sapporo, 064-8557, Japan |
BackLink | https://cir.nii.ac.jp/crid/1873116918005159296$$DView record in CiNii https://www.ncbi.nlm.nih.gov/pubmed/37793545$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kU2P1SAUhokZ43zoH3BhWLhw084BSinuzETHMZPMZkzcEUrBy5WWWqjmLv3n0rmjy0nIAU6e85H3PUcnU5wsQq8J1ARIe7mv916bmgJlNcgaqHyGzkjDRCVEByflzRpSMUq-naLzlPYARPCue4FOmRCS8YafoT8346xNxtFhPWU_erPE3uuAU7a_9TKknZ-xH-dgRztlnX2ccDl5Zx_43sfsDV7T9h1wWpOx85YOPh-wn7DGX_SsJ1uAEKfvVbbLiI1eLN7FNPusw0v03OmQ7KvH-wJ9_fTx_upzdXt3fXP14bYyjRC5co7DQPuBQG-gZ65hTmjgRpuGUsE0ZYMz1IDshW5akI7THpwExzhr-0ayC_Tu2Hde4s_VpqxGX7YNoWwX16RoJxjltANS0DeP6NqPdlDz4ke9HNQ_2QpAj0BRK6XFuv8IAbV5o_Zq80Zt3iiQqnhTit4eiybvlfFbJGUmIa0kHQAnXFLZFuz9EbNFjF_eLsqEAhsdftiDGqJ_asZfbIai6A |
Cites_doi | 10.1155/2022/2497869 10.1016/j.jhin.2009.11.022 10.1038/bmt.2012.244 10.1016/S1473-3099(13)70195-6 10.1378/chest.115.5.1378 10.2807/1560-7917.ES.2018.23.46.1800100 10.3390/pharmaceutics15020518 10.1016/S1473-3099(20)30477-1 10.2807/1560-7917.ES.2018.23.46.1800394 10.1186/s12879-021-06939-2 10.1016/j.archger.2020.104220 10.1093/jac/dkz008 10.1016/j.ajic.2018.06.019 10.2807/1560-7917.ES.23.46.1800393 10.1248/bpb.b15-00797 10.1016/j.jiac.2019.05.026 10.1111/j.1469-0691.2005.01238.x 10.1016/j.jhin.2018.11.018 10.3390/antibiotics10060680 10.1002/hep.510290406 10.1371/journal.pone.0208039 |
ContentType | Journal Article |
Copyright | 2023 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control Copyright © 2023 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd. All rights reserved. |
Copyright_xml | – notice: 2023 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control – notice: Copyright © 2023 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd. All rights reserved. |
DBID | RYH AAYXX CITATION NPM 7X8 |
DOI | 10.1016/j.jiac.2023.09.029 |
DatabaseName | CiNii Complete CrossRef PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
DatabaseTitleList | PubMed MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1437-7780 |
EndPage | 140 |
ExternalDocumentID | 37793545 10_1016_j_jiac_2023_09_029 S1341321X23002398 |
Genre | Journal Article |
GroupedDBID | --- --M -Y2 -~C .1- .55 .86 .FO .~1 0R~ 0VY 1N0 1P~ 1SB 1~. 2.D 28- 29K 2JY 2P1 2VQ 2~H 30V 4.4 408 409 40D 457 4G. 53G 5GY 5QI 5VS 67Z 6NX 7-5 8P~ 8TC 8UJ 95. 95~ AAAJQ AAEDT AAEDW AAIAL AAIKJ AAKOC AALRI AANXM AAOAW AAQFI AARHV AATTM AAXKI AAXUO AAYWO AAYZH ABFSG ABJNI ABMAC ABMNI ABMZM ABQSL ABXDB ACDAQ ACGFS ACIEU ACOMO ACRLP ACSTC ACVFH ADBBV ADCNI ADEZE ADHKG ADIMF ADKPE ADQRH ADRFC ADVLN AEBSH AEFIE AEIPS AEKER AENEX AEUPX AEVXI AEZWR AFBBN AFEXP AFHIU AFLOW AFPUW AFRHN AFTJW AFWTZ AFXIZ AGCQF AGGDS AGHFR AGJBK AGQPQ AGUBO AHBYD AHKAY AHSBF AHWEU AIEXJ AIGII AIIUN AIKHN AITUG AIXLP AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMKLP AMRAJ ANKPU ANZVX ASPBG AVWKF AXJTR AZFZN BA0 BBWZM BGNMA BKOJK BLXMC BNPGV CAG CJTIS COF CS3 CSCUP D-I DL5 EBS EFJIC EFKBS EJD EMOBN EN4 F5P FDB FEDTE FIRID FYGXN GBLVA GQ8 GXS H13 HF~ HG5 HG6 HMJXF HVGLF HZ~ I09 IHE IXC IXE IZIGR IZQ I~X KDC KOM KOW KPH LAS M41 M4Y MA- MO0 N2Q N9A NB0 NDZJH NU0 O9- O93 O9G O9I OAM OAUVE OC~ P-8 P-9 P19 P2P P9S PC. PT5 QOK QOS R4E R89 R9I RNI ROL RPX RRX RSV RZK S1Z S26 S27 S28 S37 S3B SDE SDH SDM SMD SOJ SPCBC SSH SSZ SV3 T13 T16 T5K TSK TSV TT1 TUC U2A VC2 WJK WK8 X7M Z45 Z5R ~A9 ~EX ~G- AFCTW AGRNS RYH SSI AAYXX ABTEG CITATION RIG -5E -5G -BR 0SF AACTN ADINQ AFKWA AJOXV AMFUW GQ6 NCXOZ NPM SZN Z7U Z82 Z87 Z8O Z8V Z91 7X8 |
ID | FETCH-LOGICAL-c477t-ff50d2bd10bc0b3f43f7a05cac42273a23dfc2c09b7a4609f52b0f90f3536b493 |
ISSN | 1341-321X 1437-7780 |
IngestDate | Mon Jul 21 10:10:45 EDT 2025 Wed Feb 19 02:08:39 EST 2025 Tue Jul 01 02:23:41 EDT 2025 Thu Jun 26 22:05:55 EDT 2025 Tue Aug 26 18:42:30 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | AHI Antibiotic sparing PIPC/TAZ DDD CTRX AMU GNRs Antimicrobial resistant IQR LTCHs ATC MEPM AS PPS CPZ/SBT Antimicrobial stewardship ICT ASP |
Language | English |
License | Copyright © 2023 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd. All rights reserved. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c477t-ff50d2bd10bc0b3f43f7a05cac42273a23dfc2c09b7a4609f52b0f90f3536b493 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0001-7336-0734 |
PMID | 37793545 |
PQID | 2873252801 |
PQPubID | 23479 |
PageCount | 7 |
ParticipantIDs | proquest_miscellaneous_2873252801 pubmed_primary_37793545 crossref_primary_10_1016_j_jiac_2023_09_029 nii_cinii_1873116918005159296 elsevier_clinicalkey_doi_10_1016_j_jiac_2023_09_029 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | February 2024 2024-02-01 2024-02-00 2024-Feb 20240201 |
PublicationDateYYYYMMDD | 2024-02-01 |
PublicationDate_xml | – month: 02 year: 2024 text: February 2024 |
PublicationDecade | 2020 |
PublicationPlace | Netherlands |
PublicationPlace_xml | – name: Netherlands |
PublicationTitle | Journal of Infection and Chemotherapy |
PublicationTitleAlternate | J Infect Chemother |
PublicationYear | 2024 |
Publisher | Elsevier Ltd Elsevier BV |
Publisher_xml | – name: Elsevier Ltd – name: Elsevier BV |
References | Tabak, Sung, Ye, Vankeepuram, Gupta, McCann (bib3) 2019; 102 Murayama, Kobayashi, Okamoto, Fukaya, Ishizaki, Liang (bib6) 2020; 91 Plachouras, Karki, Hansen, Hopkins, Lyytikainen, Moro (bib22) 2018; 23 Ricchizzi, Latour, Kärki, Buttazzi, Jans, Moro (bib23) 2018; 23 Niwa, Watanabe, Goto, Ohta, Nakayama, Suzuki (bib13) 2016; 39 (bib15) 2017 Madrazo, Esparcia, López-Cruz, Alberola, Piles, Viana (bib8) 2021; 21 Hattori, Maeda, Nagatomo, Takuma, Niki, Naito (bib11) 2018; 46 Tan, Guzman, Donato, Kalimuddin, Lee, Tan (bib19) 2018 Nov 28; 13 Ishibashi, Pauwels, Tomori, Gu, Yamaguchi, Handa (bib24) 2022 [accessed 10 February, 2021]. Stepan, Usaj, Ster, Galun, Smole, Bevoc (bib5) 2018; 23 Peterson (bib21) 2005; 11 Kanda (bib16) 2013; 48 Takesue, Nakajima, Ichiki, Ishihara, Wada, Takahashi (bib10) 2010; 75 Howard, Catchpole, Watson, Davies (bib1) 2013; 13 World Health Organization. ATC/DDD index 2021. Collaborating Centre for Drug Statistics Methodology Husni, Goldstein, Arroliga, Hall, Fatica, Stoller (bib18) 1999; 115 Thornley, Ashiru-Oredope, Normington, Beech, Howard (bib7) 2019; 74 Ortiz, Vila, Soriano, Miñana, Gana, Mirelis (bib17) 1999; 29 [accessed 21 April, 2022]. Ueda, Takesue, Nakajima, Ichiki, Ishikawa, Yamada (bib20) 2023; 15 Ministry of Health. Labor and Welfare. National action plan on antimicrobial resistance Kadri, Lai, Warner, Strich, Babiker, Ricotta (bib2) 2021; 21 Rodríguez-Villodres, Martín-Gandul, Peñalva, Guisado-Gil, Crespo-Rivas, Pachón-Ibáñez (bib9) 2021; 10 Yamada, Imoto, Yamairi, Shibata, Namikawa, Yoshii (bib12) 2019; 25 Rodríguez-Villodres (10.1016/j.jiac.2023.09.029_bib9) 2021; 10 Kadri (10.1016/j.jiac.2023.09.029_bib2) 2021; 21 Madrazo (10.1016/j.jiac.2023.09.029_bib8) 2021; 21 Niwa (10.1016/j.jiac.2023.09.029_bib13) 2016; 39 Ricchizzi (10.1016/j.jiac.2023.09.029_bib23) 2018; 23 Ishibashi (10.1016/j.jiac.2023.09.029_bib24) 2022 Plachouras (10.1016/j.jiac.2023.09.029_bib22) 2018; 23 Husni (10.1016/j.jiac.2023.09.029_bib18) 1999; 115 Yamada (10.1016/j.jiac.2023.09.029_bib12) 2019; 25 Howard (10.1016/j.jiac.2023.09.029_bib1) 2013; 13 Stepan (10.1016/j.jiac.2023.09.029_bib5) 2018; 23 Peterson (10.1016/j.jiac.2023.09.029_bib21) 2005; 11 10.1016/j.jiac.2023.09.029_bib4 Ortiz (10.1016/j.jiac.2023.09.029_bib17) 1999; 29 Ueda (10.1016/j.jiac.2023.09.029_bib20) 2023; 15 Kanda (10.1016/j.jiac.2023.09.029_bib16) 2013; 48 Thornley (10.1016/j.jiac.2023.09.029_bib7) 2019; 74 Takesue (10.1016/j.jiac.2023.09.029_bib10) 2010; 75 10.1016/j.jiac.2023.09.029_bib14 Tabak (10.1016/j.jiac.2023.09.029_bib3) 2019; 102 Tan (10.1016/j.jiac.2023.09.029_bib19) 2018; 13 Murayama (10.1016/j.jiac.2023.09.029_bib6) 2020; 91 Hattori (10.1016/j.jiac.2023.09.029_bib11) 2018; 46 (10.1016/j.jiac.2023.09.029_bib15) 2017 |
References_xml | – year: 2022 ident: bib24 article-title: Point prevalence surveys of antimicrobial prescribing in a non-acute care hospital in Saitama Prefecture, Japan publication-title: Can J Infect Dis Med Microbiol – volume: 46 start-page: e75 year: 2018 end-page: e79 ident: bib11 article-title: Epidemiology and risk factors for mortality in bloodstream infections: a single-center retrospective study in Japan publication-title: Am J Infect Control – volume: 102 start-page: 37 year: 2019 end-page: 44 ident: bib3 article-title: Attributable clinical and economic burden of carbapenem-non-susceptible Gram-negative infections in patients hospitalized with complicated urinary tract infections publication-title: J Hosp Infect – volume: 23 year: 2018 ident: bib23 article-title: Antimicrobial use in European long-term care facilities: results from the third point prevalence survey of healthcare-associated infections and antimicrobial use, 2016 to 2017 publication-title: Euro Surveill – reference: Ministry of Health. Labor and Welfare. National action plan on antimicrobial resistance, – volume: 13 start-page: 1001 year: 2013 end-page: 1003 ident: bib1 article-title: Antibiotic resistance: global response needed publication-title: Lancet Infect Dis – volume: 21 start-page: 241 year: 2021 end-page: 251 ident: bib2 article-title: Forming the national institutes of health antimicrobial resistance outcomes research initiative (NIH-ARORI) publication-title: Lancet Infect Dis – volume: 10 start-page: 680 year: 2021 ident: bib9 article-title: Prevalence and risk factors for multidrug-resistant organisms colonization in long-term care facilities around the world: a review publication-title: Antibiotics – reference: , [accessed 21 April, 2022]. – volume: 39 start-page: 721 year: 2016 end-page: 727 ident: bib13 article-title: Daily review of antimicrobial use facilitates the early optimization of antimicrobial therapy and improves clinical outcomes of patients with bloodstream infections publication-title: Biol Pharm Bull – reference: , [accessed 10 February, 2021]. – volume: 91 year: 2020 ident: bib6 article-title: National prevalence of frailty in the older Japanese population: findings from a nationally representative survey publication-title: Arch Gerontol Geriatr – volume: 11 start-page: 4 year: 2005 end-page: 16 ident: bib21 article-title: Squeezing the antibiotic balloon: the impact of antimicrobial classes on emerging resistance publication-title: Clin Microbiol Infect – volume: 23 year: 2018 ident: bib5 article-title: Antimicrobial prescribing in long-term care facilities: a nationwide point-prevalence study, Slovenia, 2016 publication-title: Euro Surveill – volume: 74 start-page: 1447 year: 2019 end-page: 1451 ident: bib7 article-title: Antibiotic prescribing for residents in long-term-care facilities across the UK publication-title: J Antimicrob Chemother – volume: 13 year: 2018 Nov 28 ident: bib19 article-title: Impact of an alternating first-line antibiotics strategy in febrile neutropenia publication-title: PLoS One – volume: 23 year: 2018 ident: bib22 article-title: The Point Prevalence Survey Study Group. Antimicrobial use in European acute care hospitals: results from the second point prevalence survey (PPS) of healthcare-associated infections and antimicrobial use, 2016-2017 publication-title: Euro Surveill – reference: World Health Organization. ATC/DDD index 2021. Collaborating Centre for Drug Statistics Methodology, – volume: 15 start-page: 518 year: 2023 ident: bib20 article-title: Correlation between antimicrobial resistance and the hospital-wide diverse use of broad-spectrum antibiotics by the antimicrobial stewardship program in Japan publication-title: Pharmaceutics – volume: 25 start-page: 1001 year: 2019 end-page: 1006 ident: bib12 article-title: The intervention by antimicrobial stewardship team can improve clinical and microbiological outcomes of resistant gram-negative bacteria publication-title: J Infect Chemother – volume: 29 start-page: 1064 year: 1999 end-page: 1069 ident: bib17 article-title: Infections caused by E. coli resistant to norfloxacin in hospitalized cirrhotic patients publication-title: Hepatology – volume: 48 start-page: 452 year: 2013 end-page: 458 ident: bib16 article-title: Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics publication-title: Bone Marrow Transplant – volume: 75 start-page: 28 year: 2010 end-page: 32 ident: bib10 article-title: Impact of a hospital-wide programme of heterogeneous antibiotic use on the development of antibiotic-resistant Gram-negative bacteria publication-title: J Hosp Infect – volume: 21 start-page: 1232 year: 2021 ident: bib8 article-title: Clinical impact of multidrug-resistant bacteria in older hospitalized patients with community-acquired urinary tract infection publication-title: BMC Infect Dis – year: 2017 ident: bib15 article-title: Performance standards for antimicrobial susceptibility testing – volume: 115 start-page: 1378 year: 1999 end-page: 1382 ident: bib18 article-title: Risk factors for an outbreak of multidrug-resistant Acinetobacter nosocomial pneumonia among intubated patients publication-title: Chest – year: 2022 ident: 10.1016/j.jiac.2023.09.029_bib24 article-title: Point prevalence surveys of antimicrobial prescribing in a non-acute care hospital in Saitama Prefecture, Japan publication-title: Can J Infect Dis Med Microbiol doi: 10.1155/2022/2497869 – volume: 75 start-page: 28 year: 2010 ident: 10.1016/j.jiac.2023.09.029_bib10 article-title: Impact of a hospital-wide programme of heterogeneous antibiotic use on the development of antibiotic-resistant Gram-negative bacteria publication-title: J Hosp Infect doi: 10.1016/j.jhin.2009.11.022 – volume: 48 start-page: 452 year: 2013 ident: 10.1016/j.jiac.2023.09.029_bib16 article-title: Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics publication-title: Bone Marrow Transplant doi: 10.1038/bmt.2012.244 – volume: 13 start-page: 1001 year: 2013 ident: 10.1016/j.jiac.2023.09.029_bib1 article-title: Antibiotic resistance: global response needed publication-title: Lancet Infect Dis doi: 10.1016/S1473-3099(13)70195-6 – volume: 115 start-page: 1378 year: 1999 ident: 10.1016/j.jiac.2023.09.029_bib18 article-title: Risk factors for an outbreak of multidrug-resistant Acinetobacter nosocomial pneumonia among intubated patients publication-title: Chest doi: 10.1378/chest.115.5.1378 – ident: 10.1016/j.jiac.2023.09.029_bib4 – volume: 23 year: 2018 ident: 10.1016/j.jiac.2023.09.029_bib5 article-title: Antimicrobial prescribing in long-term care facilities: a nationwide point-prevalence study, Slovenia, 2016 publication-title: Euro Surveill doi: 10.2807/1560-7917.ES.2018.23.46.1800100 – volume: 15 start-page: 518 year: 2023 ident: 10.1016/j.jiac.2023.09.029_bib20 article-title: Correlation between antimicrobial resistance and the hospital-wide diverse use of broad-spectrum antibiotics by the antimicrobial stewardship program in Japan publication-title: Pharmaceutics doi: 10.3390/pharmaceutics15020518 – volume: 21 start-page: 241 year: 2021 ident: 10.1016/j.jiac.2023.09.029_bib2 article-title: Forming the national institutes of health antimicrobial resistance outcomes research initiative (NIH-ARORI) publication-title: Lancet Infect Dis doi: 10.1016/S1473-3099(20)30477-1 – year: 2017 ident: 10.1016/j.jiac.2023.09.029_bib15 – volume: 23 year: 2018 ident: 10.1016/j.jiac.2023.09.029_bib23 article-title: Antimicrobial use in European long-term care facilities: results from the third point prevalence survey of healthcare-associated infections and antimicrobial use, 2016 to 2017 publication-title: Euro Surveill doi: 10.2807/1560-7917.ES.2018.23.46.1800394 – volume: 21 start-page: 1232 year: 2021 ident: 10.1016/j.jiac.2023.09.029_bib8 article-title: Clinical impact of multidrug-resistant bacteria in older hospitalized patients with community-acquired urinary tract infection publication-title: BMC Infect Dis doi: 10.1186/s12879-021-06939-2 – ident: 10.1016/j.jiac.2023.09.029_bib14 – volume: 91 year: 2020 ident: 10.1016/j.jiac.2023.09.029_bib6 article-title: National prevalence of frailty in the older Japanese population: findings from a nationally representative survey publication-title: Arch Gerontol Geriatr doi: 10.1016/j.archger.2020.104220 – volume: 74 start-page: 1447 year: 2019 ident: 10.1016/j.jiac.2023.09.029_bib7 article-title: Antibiotic prescribing for residents in long-term-care facilities across the UK publication-title: J Antimicrob Chemother doi: 10.1093/jac/dkz008 – volume: 46 start-page: e75 year: 2018 ident: 10.1016/j.jiac.2023.09.029_bib11 article-title: Epidemiology and risk factors for mortality in bloodstream infections: a single-center retrospective study in Japan publication-title: Am J Infect Control doi: 10.1016/j.ajic.2018.06.019 – volume: 23 year: 2018 ident: 10.1016/j.jiac.2023.09.029_bib22 article-title: The Point Prevalence Survey Study Group. Antimicrobial use in European acute care hospitals: results from the second point prevalence survey (PPS) of healthcare-associated infections and antimicrobial use, 2016-2017 publication-title: Euro Surveill doi: 10.2807/1560-7917.ES.23.46.1800393 – volume: 39 start-page: 721 year: 2016 ident: 10.1016/j.jiac.2023.09.029_bib13 article-title: Daily review of antimicrobial use facilitates the early optimization of antimicrobial therapy and improves clinical outcomes of patients with bloodstream infections publication-title: Biol Pharm Bull doi: 10.1248/bpb.b15-00797 – volume: 25 start-page: 1001 year: 2019 ident: 10.1016/j.jiac.2023.09.029_bib12 article-title: The intervention by antimicrobial stewardship team can improve clinical and microbiological outcomes of resistant gram-negative bacteria publication-title: J Infect Chemother doi: 10.1016/j.jiac.2019.05.026 – volume: 11 start-page: 4 year: 2005 ident: 10.1016/j.jiac.2023.09.029_bib21 article-title: Squeezing the antibiotic balloon: the impact of antimicrobial classes on emerging resistance publication-title: Clin Microbiol Infect doi: 10.1111/j.1469-0691.2005.01238.x – volume: 102 start-page: 37 year: 2019 ident: 10.1016/j.jiac.2023.09.029_bib3 article-title: Attributable clinical and economic burden of carbapenem-non-susceptible Gram-negative infections in patients hospitalized with complicated urinary tract infections publication-title: J Hosp Infect doi: 10.1016/j.jhin.2018.11.018 – volume: 10 start-page: 680 year: 2021 ident: 10.1016/j.jiac.2023.09.029_bib9 article-title: Prevalence and risk factors for multidrug-resistant organisms colonization in long-term care facilities around the world: a review publication-title: Antibiotics doi: 10.3390/antibiotics10060680 – volume: 29 start-page: 1064 year: 1999 ident: 10.1016/j.jiac.2023.09.029_bib17 article-title: Infections caused by E. coli resistant to norfloxacin in hospitalized cirrhotic patients publication-title: Hepatology doi: 10.1002/hep.510290406 – volume: 13 issue: 11 year: 2018 ident: 10.1016/j.jiac.2023.09.029_bib19 article-title: Impact of an alternating first-line antibiotics strategy in febrile neutropenia publication-title: PLoS One doi: 10.1371/journal.pone.0208039 |
SSID | ssj0017588 ssib050995435 ssib002821768 ssib058493233 |
Score | 2.3498135 |
Snippet | Antimicrobial use (AMU) is closely related to the emergence of antimicrobial-resistant (AMR) bacteria. Meanwhile, long-term care hospitals (LTCHs) have been... |
SourceID | proquest pubmed crossref nii elsevier |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 134 |
SubjectTerms | Antibiotic sparing Antimicrobial resistant Antimicrobial stewardship |
Title | Impact of antimicrobial stewardship implementation on the antibiotic use and susceptibility in a Japanese long-term care hospital |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S1341321X23002398 https://cir.nii.ac.jp/crid/1873116918005159296 https://www.ncbi.nlm.nih.gov/pubmed/37793545 https://www.proquest.com/docview/2873252801 |
Volume | 30 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwGLXYeOEFcaeMISOhvWSpEjuX5hEh0DZUtIcOjSfLdmrmbk2mJX0oD0j8cz7buRUoN6mK2ih1o5xT-9g-3_ch9IrAGCzCUPqhFJkfzbPE55kwToBJEuQRlzw3O7rTD8nRWXRyHp_32wU2uqQWY_nll3El_4MqnANcTZTsPyDbNQon4D3gC0dAGI5_hfFxH-JY1HqpbVIlGwAyN2ZYa8TSy9Yh7rShszWa64UuTbbWVeV2EKpVZS0u1i1rowG5dwJDqSlR6V2VxWff9OI2lbV30VQb2SJtjxuHlzM6m5wETZzXwHJ8WYLqfb8yloK1KejULyFczi_0Tel94kveLxdMeWWu8mblUtf9WV3wpfamvIbHDg0O1zBI1Nqe24W1Lrjm46ArhvHVp8QW1On66mYPx3W2YbMM6sbt0KV9-mlIcKsTi_FCc5OyklCb15ZkO-g2gamFqXox_roRyxsOpmCgp7J4IClBr4Hipd1oD-rL1jbt7rYJzHIewh9_c5v42Sm03j7FsVJndg_dbYDErx3h7qNbC_4AHZy6JOfrQzzrY_aqQ3yAT_v05-uH6JtjJS4V3mAlHrASb7ISwwsIgntWYmAlfMzxJiuxLjDHLStxx0psWIlbVj5CZ-_ezt4c-U2hD19GaVr7SsVBTkQeBkIGgqqIqpQHseQyIiCvOaG5kkQGmUh5lASZiokIVBYoGtNEACCP0W5RFvOnCNNEgkDPBEkFBQ0A0xNFcgkqLMlzoZJ0hLwWAXbt8rmw1ui4YAYvZvBiQcYArxGiLUisjVSGsZUBt377rX3Ak0ltjuEkpaHJSDWx5ZRgNpKM0MsWaQadudmhg6dWripG4GISE1CNI_TEUaC7S5MZlMJ859kfWt9Dd_q_2HO0W9-s5vsgnGvxwjL9O0ZMw4E |
linkProvider | Elsevier |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Impact+of+antimicrobial+stewardship+implementation+on+the+antibiotic+use+and+susceptibility+in+a+Japanese+long-term+care+hospital&rft.jtitle=Journal+of+Infection+and+Chemotherapy&rft.au=Makoto+Kurabayashi&rft.au=Takehiro+Yamada&rft.au=Masashi+Tomita&rft.au=Minami+Matsumoto&rft.date=2024-02-01&rft.pub=Elsevier+BV&rft.issn=1341-321X&rft.volume=30&rft.spage=134&rft.epage=140&rft_id=info:doi/10.1016%2Fj.jiac.2023.09.029 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1341-321X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1341-321X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1341-321X&client=summon |